Therefore, our findings support the view that targeting the GPR55 with cannabinoids able to activate this receptor may afford neuroprotection in experimental PD, in particular, in models associated with mitochondrial dysfunction as in 6-OHDA-lesioned mice. The gene discussed is GPR55; the disease is Parkinson disease.